172 related articles for article (PubMed ID: 28160128)
1. Blockade of the kinin B1 receptor affects the cytokine/chemokine profile in rat brain subjected to autoimmune encephalomyelitis.
Podsiadło K; Sulkowski G; Dąbrowska-Bouta B; Strużyńska L
Inflammopharmacology; 2017 Aug; 25(4):459-469. PubMed ID: 28160128
[TBL] [Abstract][Full Text] [Related]
2. The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes.
Dutra RC; Bento AF; Leite DF; Manjavachi MN; Marcon R; Bicca MA; Pesquero JB; Calixto JB
Neurobiol Dis; 2013 Jun; 54():82-93. PubMed ID: 23454198
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
4. Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema.
Austinat M; Braeuninger S; Pesquero JB; Brede M; Bader M; Stoll G; Renné T; Kleinschnitz C
Stroke; 2009 Jan; 40(1):285-93. PubMed ID: 18988906
[TBL] [Abstract][Full Text] [Related]
5. Role of selective blocking of bradykinin B1 receptor in attenuating immune liver injury in trichloroethylene-sensitized mice.
Zhang J; Li N; Yang L; Zang D; Yang P; Wang H; Shen T; Zhu QX
Cytokine; 2018 Aug; 108():71-81. PubMed ID: 29579546
[TBL] [Abstract][Full Text] [Related]
6. Early P2X7R-dependent activation of microglia during the asymptomatic phase of autoimmune encephalomyelitis.
Grygorowicz T; Strużyńska L
Inflammopharmacology; 2019 Feb; 27(1):129-137. PubMed ID: 30209761
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal Regulatory Interaction between TRPV1 and Kinin B1 Receptor in a Rat Neuropathic Pain Model.
Cernit V; Sénécal J; Othman R; Couture R
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012798
[TBL] [Abstract][Full Text] [Related]
8. Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: the role of kallikrein-kinin system.
Dutra RC; Moreira EL; Alberti TB; Marcon R; Prediger RD; Calixto JB
Brain Behav Immun; 2013 Oct; 33():90-101. PubMed ID: 23777652
[TBL] [Abstract][Full Text] [Related]
9. Kinin B1 Receptor Blockade Prevents Angiotensin II-induced Neuroinflammation and Oxidative Stress in Primary Hypothalamic Neurons.
Parekh RU; Robidoux J; Sriramula S
Cell Mol Neurobiol; 2020 Jul; 40(5):845-857. PubMed ID: 31865500
[TBL] [Abstract][Full Text] [Related]
10. Blockade of hippocampal bradykinin B1 receptors improves spatial learning and memory deficits in middle-aged rats.
Bitencourt RM; Guerra de Souza AC; Bicca MA; Pamplona FA; de Mello N; Passos GF; Medeiros R; Takahashi RN; Calixto JB; Prediger RD
Behav Brain Res; 2017 Jan; 316():74-81. PubMed ID: 27566183
[TBL] [Abstract][Full Text] [Related]
11. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.
Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J
J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535
[TBL] [Abstract][Full Text] [Related]
12. Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation.
Albert-Weissenberger C; Stetter C; Meuth SG; Göbel K; Bader M; Sirén AL; Kleinschnitz C
J Cereb Blood Flow Metab; 2012 Sep; 32(9):1747-56. PubMed ID: 22569191
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis.
Qin L; Du Y; Ding H; Haque A; Hicks J; Pedroza C; Mohan C
Arthritis Res Ther; 2019 Jan; 21(1):12. PubMed ID: 30621761
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the kinin B
de Souza Maciel I; Azevedo VM; Oliboni P; Campos MM
Behav Brain Res; 2021 Aug; 412():113439. PubMed ID: 34197868
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta enhances the action of bradykinin in rat myenteric neurons through up-regulation of glial B1 receptor expression.
Murakami M; Ohta T; Ito S
Neuroscience; 2008 Jan; 151(1):222-31. PubMed ID: 18053651
[TBL] [Abstract][Full Text] [Related]
16. Protective action of B1R antagonist against cerebral ischemia-reperfusion injury through suppressing miR-200c expression of Microglia-derived microvesicles.
Tang M; Liu P; Li X; Wang JW; Zhu XC; He FP
Neurol Res; 2017 Jul; 39(7):612-620. PubMed ID: 28398146
[TBL] [Abstract][Full Text] [Related]
17. Effects of antagonists of glutamate receptors on pro-inflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis.
Sulkowski G; Dąbrowska-Bouta B; Chalimoniuk M; Strużyńska L
J Neuroimmunol; 2013 Aug; 261(1-2):67-76. PubMed ID: 23746391
[TBL] [Abstract][Full Text] [Related]
18. Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.
Borjini N; Fernández M; Giardino L; Calzà L
J Neuroinflammation; 2016 Nov; 13(1):291. PubMed ID: 27846891
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin B1 receptor expression induced by tissue damage in the rat portal vein: a critical role for mitogen-activated protein kinase and nuclear factor-kappaB signaling pathways.
Medeiros R; Cabrini DA; Ferreira J; Fernandes ES; Mori MA; Pesquero JB; Bader M; Avellar MC; Campos MM; Calixto JB
Circ Res; 2004 May; 94(10):1375-82. PubMed ID: 15087417
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model.
Hess JF; Ransom RW; Zeng Z; Chang RS; Hey PJ; Warren L; Harrell CM; Murphy KL; Chen TB; Miller PJ; Lis E; Reiss D; Gibson RE; Markowitz MK; DiPardo RM; Su DS; Bock MG; Gould RJ; Pettibone DJ
J Pharmacol Exp Ther; 2004 Aug; 310(2):488-97. PubMed ID: 15051800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
